3-methyl-pyrrolidine-2,5-dione derivatives useful as CGRP receptor antagonists
申请人:Eli Lilly and Company
公开号:US10336726B2
公开(公告)日:2019-07-02
The present invention provides a compound of Formula II:
or a pharmaceutically acceptable salt or hydrate thereof, useful as a CGRP receptor antagonist.